Beijing Scitop Bio Tech Co Ltd Net Asset Quality Index
Beijing Scitop Bio Tech Co Ltd net asset quality index. Beijing Scitop Bio Tech Co Ltd (300858) has a Net Asset Quality Index of 88.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.03 Billion minus total liabilities of CN¥236.16 Million yields net assets of CN¥1.79 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 300858 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Beijing Scitop Bio Tech Co Ltd (2015–2025)
Net asset quality index of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. This chart shows how Beijing Scitop Bio Tech Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the index stands at 88.4%, representing net assets of CN¥1.79 Billion against total assets of CN¥2.03 Billion CNY. See net assets of Beijing Scitop Bio Tech Co Ltd for net asset value and shareholders' equity analysis.
Beijing Scitop Bio Tech Co Ltd Net Asset Quality Index by Year (2015–2025)
Beijing Scitop Bio Tech Co Ltd net asset quality index by year from 2015 to 2025. The table below presents the year-by-year Net Asset Quality Index for Beijing Scitop Bio Tech Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Beijing Scitop Bio Tech Co Ltd worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 91.3% | CN¥1.84 Billion | CN¥2.02 Billion | CN¥176.08 Million | ▼ -2.1 pp |
| 2024 | 93.4% | CN¥1.79 Billion | CN¥1.92 Billion | CN¥126.03 Million | ▼ -2.3 pp |
| 2023 | 95.7% | CN¥1.73 Billion | CN¥1.81 Billion | CN¥77.10 Million | ▲ +1.0 pp |
| 2022 | 94.8% | CN¥1.70 Billion | CN¥1.79 Billion | CN¥93.99 Million | ▲ +1.8 pp |
| 2021 | 93.0% | CN¥967.40 Million | CN¥1.04 Billion | CN¥73.33 Million | ▼ -0.4 pp |
| 2020 | 93.3% | CN¥932.59 Million | CN¥999.25 Million | CN¥66.66 Million | ▲ +7.5 pp |
| 2019 | 85.8% | CN¥399.83 Million | CN¥465.97 Million | CN¥66.14 Million | ▲ +5.0 pp |
| 2018 | 80.8% | CN¥301.83 Million | CN¥373.74 Million | CN¥71.91 Million | ▼ -2.6 pp |
| 2017 | 83.3% | CN¥281.09 Million | CN¥337.39 Million | CN¥56.30 Million | ▲ +10.2 pp |
| 2016 | 73.1% | CN¥194.57 Million | CN¥266.26 Million | CN¥71.69 Million | ▲ +44.5 pp |
| 2015 | 28.5% | CN¥52.67 Million | CN¥184.55 Million | CN¥131.89 Million | — |